An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 210315
Company: MAIA PHARMS INC

Products on ANDA 210315

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
BACLOFEN	BACLOFEN	1MG/ML	INJECTABLE;INTRATHECAL	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 210315

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
07/30/2019	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 210315

BACLOFEN

INJECTABLE;INTRATHECAL; 1MG/ML
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BACLOFEN	BACLOFEN	1MG/ML	INJECTABLE;INTRATHECAL	Prescription	No	AP	210315	MAIA PHARMS INC
BACLOFEN	BACLOFEN	1MG/ML	INJECTABLE;INTRATHECAL	Prescription	No	AP	209594	MYLAN LABS LTD
BACLOFEN	BACLOFEN	1MG/ML	INJECTABLE;INTRATHECAL	Prescription	No	AP	217324	RUBICON
GABLOFEN	BACLOFEN	1MG/ML	INJECTABLE;INTRATHECAL	Prescription	Yes	AP	022462	PIRAMAL CRITICAL

Top